Protara Therapeutics (TARA) Amortizatization of Intangibles (2013 - 2026)
Protara Therapeutics' (TARA) quarterly Amortizatization of Intangibles came in at -$190000.0 in Q1 2026, down 14.46% year-on-year from -$222112.7 in Q1 2025, and up 40.06% on a QoQ basis from -$317000.0 in Q4 2025.
Protara Therapeutics (TARA) Amortizatization of Intangibles (2013 - 2026) Analysis & Trends
Protara Therapeutics (TARA) has 13 years of Amortizatization of Intangibles data on file, last reported at -$190000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 14.46% year-over-year to -$190000.0 in Q1 2026; TTM through Mar 2026 was -$1.3 million, a 62.07% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 million, down 81.75% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at -$190000.0, up from -$317000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for TARA reached as high as $410000.0 in Q1 2022 and fell as low as -$396000.0 in Q3 2025.
- Historically, Amortizatization of Intangibles has averaged -$83941.2 across 5 years, with a median of -$127000.0 in 2023.
- Across the five-year window, Amortizatization of Intangibles jumped 94.74% in 2024 and tumbled 5128.57% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $108000.0 in 2022, then tumbled by 204.63% to -$113000.0 in 2023, then tumbled by 146.9% to -$279000.0 in 2024, then fell by 13.62% to -$317000.0 in 2025, then soared by 40.06% to -$190000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were -$190000.0 in Q1 2026, -$317000.0 in Q4 2025, and -$396000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Protara Therapeutics | 232.74 Mn | 232.74 Mn | - | -190,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -190,000.00 |
| Mar 31, 2026 | -190,000.00 |
| Dec 31, 2025 | -317,000.00 |
| Dec 31, 2025 | -317,000.00 |
| Sep 30, 2025 | -396,000.00 |
| Sep 30, 2025 | -396,000.00 |
| Jun 30, 2025 | -366,000.00 |
| Jun 30, 2025 | -366,000.00 |
| Mar 31, 2025 | -166,000.00 |
| Mar 31, 2025 | -166,000.00 |
| Dec 31, 2024 | -279,000.00 |
| Dec 31, 2024 | -279,000.00 |
| Sep 30, 2024 | -331,000.00 |
| Sep 30, 2024 | -331,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | -68,000.00 |
| Mar 31, 2024 | -68,000.00 |
| Dec 31, 2023 | -113,000.00 |
| Dec 31, 2023 | -113,000.00 |